GSK offers concessions to address Pfizer deal concerns Farhat Nasim23 Jun 2019 8:59 AM ISTGSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
GSK eyes sale of $1.2 billion consumer health drugs; says report Medical Dialogues Bureau22 Jun 2019 8:59 AM ISTGSK is streamlining its product offering as it prepares to fold its consumer business into a joint venture with Pfizer in the second half of this...
GSK forms drug discovery alliance with University of California CRISPR researchers Medical Dialogues Bureau14 Jun 2019 12:24 PM ISTBritish drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of...
GSK Nucala wins USFDA approval for two new self-administration options Farhat Nasim9 Jun 2019 10:00 AM ISTNucala is the first anti-IL5 biologic to be licensed in the US for at-home administration, and the first respiratory biologic to be approved for...
GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma Medical Dialogues Bureau8 Jun 2019 10:00 AM ISTThe price tag for the mainly Europe-focused brand portfolio, which includes itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough...
GSK Consumers Healthcare gets shareholders' nod for merger with HUL Medical Dialogues Bureau3 Jun 2019 9:30 AM ISTEarlier in January, GlaxoSmithKline (GSK) Consumer Healthcare had informed that it has received approval from the fair trade regulator CCI for its...
GSK, Pfizer gets CCI approval for consumer healthcare JV formation Garima25 May 2019 9:45 AM ISTAfter the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
GSK reintroduce incentives for sales representatives Farhat Nasim24 May 2019 9:31 AM ISTGSK said it would make changes to its incentive program for pharmaceutical and vaccines sales representatives, to be applied initially in the United...
CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups Meghna A Singhania22 May 2019 5:25 PM ISTNew Delhi: One of the oldest pharmaceutical and healthcare companies in India, GlaxoSmithKline recently presented before the Subject Expert Committee...
GSK Pharma Q4 net profit rises 16.56 percent to Rs 123 crore Garima21 May 2019 9:30 AM ISTThe company had posted a net profit of Rs 105.55 crore for the corresponding period of the previous fiscal, GSK said in a filing to the BSE.New Delhi:...
GSK Consumer Healthcare Q4 profit up 35 percent to Rs 285 crore Garima11 May 2019 9:35 AM ISTIn a separate filing, GSK Consumer Healthcare informed that its board has recommended a dividend at the rate of Rs 105 per equity share of Rs 10...
GSK expects shingles drug sales to exceed $1.3 billion Garima2 May 2019 9:00 AM ISTFTSE-100 member GSK, whose shares were up 0.3 per cent to 1,580 pence at 1156 GMT, also said it had decided to stop the clinical development of its...
